Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, Metformin), By Route of Administration (Oral and Parenteral), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2024

Code : CMI2665

Pages :145

Formats :

Excel and PDF

Industry : Pharmaceutical

Infertility Drugs Market Size and Trends

Global infertility drugs market is estimated to be valued at USD 3.91 Bn in 2024 and is expected to reach USD 6.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

Infertility Drugs Market Key Factors

To learn more about this report, request sample copy

Increasing prevalence of infertility issues due to lifestyle changes, rising stress levels, and obesity can drive the global infertility drugs market. Rising healthcare expenditure, growing awareness regarding infertility treatments, technological advancements in fertility treatment techniques, and availability of reimbursement coverage for fertility treatments in developed countries can boost demand for infertility drugs. However, high cost of infertility treatment and procedures, lack of awareness in developing nations, adverse effects associated with use of fertility drugs, and social stigma related to infertility issues in certain regions can hamper the market growth during the forecast period.

Advances in Assisted Reproductive Technologies

In recent years, there have been significant advancements in assisted reproductive technologies for treating infertility issues. Technologies such as IVF, ICSI, and surrogacy have enabled many couples to fulfill their dreams of having children. Success rates of IVF cycles have improved due to better understanding of human reproductive biology as well as refinements in laboratory procedures. Furthermore, egg freezing has emerged as a viable option for women looking to delay pregnancy but preserve their fertility. This has especially benefited women focusing on their careers. The availability of these technologies in standard fertility clinics and IVF centers across major cities has made them accessible to more people. Growing demand for these technologies can boost need for infertility drugs that help stimulate egg production, facilitate sperm collection, prepare the endometrium, and support early pregnancy. New drugs that specifically target underlying causes of infertility are also entering the market. The continuous technological breakthroughs in this area and rising ability to pay for them in developing markets can boosts use of related fertility medications.

/p>

Rise in Risk Factors Associated with Infertility

Various lifestyle and environmental factors contribute to risk factors linked with infertility. Delayed childbearing driven by social and economic reasons has increased the chances of age-related infertility in women. Furthermore, triple health burden of obesity, diabetes, and hypertension can also negatively impact fertility and make conception difficult. Changing dietary patterns have also altered hormonal balances in both men and women. Exposure to toxins and chemicals through polluted air and water as well as certain occupational hazards are raising concerns about their effects on reproductive health. The resultant stresses on reproductive systems signal a growing need for medical assistance. This makes infertility drugs an increasingly important component of the initial evaluation and treatment process.